Advanced search
Publication Cover
Platelets Volume 33, 2022 - Issue 4
Submit an article Journal homepage
161
Views
5
CrossRef citations to date
0
Altmetric
Case Studies

Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura

Mathilde ChanutCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceView further author information
,
Rym JaidiCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceView further author information
,
Milena KohnCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceView further author information
,
Thomas GrangeCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceView further author information
,
Clara BronesCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceView further author information
,
Naëlle LombionCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceView further author information
,
Philippe RousselotCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceView further author information
&
Thomas LongvalCentre Hospitalier de Versailles, Hematologie Oncologie, Le Chesnay, FranceCorrespondence[email protected]
View further author information
 show all
Pages 652-653 | Received 18 Jan 2022, Accepted 15 Feb 2022, Published online: 28 Feb 2022

References

  • Sauvé LJ, Bettinger J, Scheifele D, Halperin S, Vaudry W, Law B. Postvaccination thrombocytopenia in Canada. Pediatr Infect Dis J 2010;29:559–561. doi:10.1097/INF.0b013e3181d2bb45.
  • Lee E, Douglas, B, Terry, G, Craig, K, Marc, M, Marc, M, Michael, D, John, W, Donald, M, Bertrand, G, Michele, P, James, B. Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination. Am J Hematol 2021;96:534–537. doi:10.1002/ajh.26132.
  • Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for management of immune thrombocytopenia during COVID‐19 pandemic. J Med Virol 2020;92:2277–2282. doi:10.1002/jmv.26251.
  • Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica 2005;90:829–832.
  • Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190–4207. doi:10.1182/blood-2010-08-302984.
  • Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Haas EJ, Milo R, Alroy-Preis S, Ash N, Huppert A, et al. Waning Immunity after the BNT162b2 vaccine in Israel. N Engl J Med 2021;385:e85. doi:10.1056/NEJMoa2114228.
  • Widge AT, Rouphael NG, Jackson LA, Anderson EJ, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med 2021;384:80–82. doi:10.1056/NEJMc2032195.
  • Kennedy BS, Richeson RP, Houde AJ. Risk factors for SARS-CoV-2 in a statewide correctional system. N Engl J Med 2020;383:2479–2480. doi:10.1056/NEJMc2029354.
  • Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, et al. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet Lond Engl 2021;398:121–130. doi:10.1016/S0140-6736(21)01420-3.
  • Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021;385:585–594. doi:10.1056/NEJMoa2108891.
  • Battegay R, Istampoulouoglou I, Holbro A, Buser A, Hirsiger JR, Eckstein J, Berger CT, Koechlin S, Leuppi-Taegtmeyer AB. Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data. Swiss Med Wkly 2021;151:w30084. doi:10.4414/smw.2021.w30084.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.